Wholesaler is negotiating with Bristol-Myers Squibb "discussing whether or not" an inventory management agreement "may work for us and for them," McKesson Supply Solutions President Paul Julian says during fiscal Q4 call April 29. The two companies currently are not operating under an IMA. Cardinal CEO Robert Walter has said the wholesaler believes BMS' new inventory management program undervalues Cardinal's current services (1"The Pink Sheet" April 28, p. 15)...
You may also be interested in...
Cardinal is renegotiating its arrangement with Bristol-Myers Squibb because the wholesaler feels the current deal undervalues its services
CBER Director Peter Marks said the agency could streamline development by allowing sponsors to depend on an already-approved manufacturing platform and reviewing any modifications that are proposed.
Only 12 US jurisdictions currently have sound COVID-19 virus assays from the Centers for Disease Control and Prevention to test suspected virus cases, CDC director Robert Redfield told a House panel looking at virus preparedness on Wednesday – but a better batch is coming, he said. Other questions raised at the congressional hearing was how long an infected person stays infected, whether COVID-19 can be picked up from inanimate surfaces, and related queries.